Precision therapeutics for the brain
Alto is transforming mental health by developing a new generation of psychiatric drugs that are more effective by virtue of personalization, achieved by integrating biomarkers into drug development
Alto was born out of work in the Stanford lab of CEO and Founder Amit Etkin, MD PhD. Dr. Etkin is a Professor of Psychiatry at Stanford (bio), where he has led a highly interdisciplinary lab aimed at understanding the brain basis of psychiatric disease and developing novel treatments. In recognition of his groundbreaking vision, Dr. Etkin received the highly prestigious NIH Director’s Pioneer Award in 2017.
The scientific underpinnings of this work has, and continues to be, published in many of the most impactful journals in biology and medicine: